🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

14,283 results for “B” Clear

  1. Use of an Implantable Loop Recorder

    Rhythm Pharmaceuticals Netherlands B.V.

    Syncope

    approved other completed

    1 trial

  2. VAB-7

    The First People's Hospital of Lianyungang

    Helicobacter Pylori

    approved small molecule active

    1 trial

  3. VERAPAMIL , NEBIVOLOL , PROPAFENONE , BISOPROLOL , AMIODARONE , FLECAINIDE , SOTALOL , DILTIAZEM

    Pari Pharma GmbH

    Asymptomatic Patients with frequent PVCs and normal LVEF

    approved small molecule active

    1 trial

  4. VYDURA 75 mg oral lyophilisate, Placebo for Rimegepant 75 mg

    Pfizer Australia Pty Ltd

    Migraine attacks with or without aura

    approved small molecule active

    1 trial

  5. VYEPTI 100 mg concentrate for solution for infusion

    H. Lundbeck A/S

    Chronic Migrane, Migrane, Medication Overuse Headache

    approved small molecule active

    1 trial

  6. Vabysmo 120 mg/mL solution for injection

    Hoffmann-La Roche

    Neovascular Age-Related Macular Degeneration

    approved small molecule active

    1 trial

  7. Vabysmo 120 mg/mL solution for injection in pre-filled syringe

    The George Institute

    SUBRETINAL HYPERREFLECTIVE MATERIAL

    approved small molecule active

    1 trial

  8. Vaccination to prevent hepatitis B virus infection

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis B

    approved mab completed

    1 trial

  9. Valbenazine

    NEUROCRINE BIOSCIENCES INC

    Schizophrenia

    approved small molecule active

    3 trials

  10. Valbenazine

    NEUROCRINE BIOSCIENCES INC

    Tardive Dyskinesia (TD)

    approved small molecule completed

    2 trials

  11. Valbenazine Oral Capsule

    NEUROCRINE BIOSCIENCES INC

    Tardive Dyskinesia

    approved small molecule terminated

    1 trial

  12. Vancomycin

    The First People's Hospital of Lianyungang

    Blood Stream Infections

    approved small molecule active

    1 trial

  13. Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Parkinson's Disease

    approved small molecule terminated

    1 trial

  14. Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    approved small molecule completed

    3 trials

  15. Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia

    approved small molecule completed

    2 trials

  16. Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Vaping

    approved small molecule terminated

    1 trial

  17. Vedolizumab

    Takeda

    Crohn Disease

    approved small molecule terminated

    4 trials

  18. Vedolizumab

    Takeda

    Crohn's Disease

    approved small molecule active

    6 trials

  19. Vedolizumab

    Second Affiliated Hospital of Soochow University

    Ulcerative Colitis (UC)

    approved mab completed

    1 trial

  20. Vedolizumab

    Takeda

    Moderately to Severely Active Crohn's Disease

    approved mab active

    1 trial

  21. Vedolizumab 300 mg

    Takeda

    Colitis, Ulcerative

    approved small molecule completed

    1 trial

  22. Vedolizumab IV

    Takeda

    Colitis, Ulcerative

    approved small molecule completed

    1 trial

  23. Vedolizumab Placebo

    Takeda

    Pouchitis

    approved small molecule completed

    1 trial

  24. Vemlidy

    Hospital Authority, Hong Kong

    Chronic Hepatitis b

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources